CNS Pharmaceuticals CNSP 深 沪
已收盘 02-06 16:00:00 美东时间
4.51
-0.040
-0.88%
华盛通- 最 高4.73
- 今 开4.50
- 成交量 2.30万股
- 最 低 4.34
- 昨 收 4.55
- 总市值 279.75万
- 52周最高 55.20
- 市盈率 静 --
- 换手率 3.71%
- 52周最低 4.34
- 委 比 33.33%
- 总股本 62.03万
- 历史最高 5121000.00
- 量 比 1.20
- 振 幅 8.57%
- 历史最低 4.34
- 每 手 1
- 风险率 13.30%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多CNS Pharmaceuticals Inc. Outlines Strategy to Sharpen Focus, Optimize Pipeline, and Align Capital Allocation for Long-Term Value Creation
CNS Pharmaceuticals Inc. Outlines Strategy to Sharpen Focus, Optimize Pipeline, and Align Capital Allocation for Long-Term Value Creation CNS Pharmaceuticals Inc. has announced a strategic plan focused on transforming its operations to create long-term value for shareholders. The newly appointed Pre
01-27 22:51
CNS Pharmaceuticals Announces New CEO Appointment
The latest announcement is out from CNS Pharmaceuticals ( ($CNSP) ). On Decembe...
2025-12-17 21:58
CNS Pharmaceuticals CEO John Climaco Steps Down, Rami Levin Named New Chief Executive
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous
2025-12-17 20:08
CNS Pharmaceuticals Increases Authorized Shares for Growth
CNS Pharmaceuticals ( ($CNSP) ) just unveiled an update. On November 17, 2025, ...
2025-11-22 06:51
CNS Pharmaceuticals Reports Financial Gains Amid Ongoing R&D
Cns Pharmaceuticals, Inc. ( ($CNSP) ) has released its Q3 earnings. Here is a b...
2025-11-18 12:00
Belgium purchases kamikaze drones to protect air space
Belgium plans to acquire loitering munitions from a Latvian manufacturer as it responds to a wave of mysterious drone incursions that have briefly shut down airports, disrupted military facilities and...
2025-11-18 02:25
CNS Pharmaceuticals Q3 EPS $(5.76) Beats $(7.09) Estimate
CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(5.76) per share which beat the analyst consensus estimate of $(7.09) by 18.82 percent. This is a 96.24 percent increase over losses of $(153.20) per share
2025-11-17 22:43
Avadel Pharmaceuticals Settles Lawsuits with Jazz Pharmaceuticals
Avadel Pharmaceuticals ( ($AVDL) ) has shared an announcement. On October 21, 2...
2025-10-22 18:58
美股大行评级 | 潜在涨幅280.95%！HC Wainwright & Co.上调Immix Biopharma目标价至8美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从7美元升至8美元；Maxim Group：上调CNS Pharma评级至"买入"，目标价20美元
2025-09-15 11:13
Maxim Group Upgrades CNS Pharma to Buy, Announces $20 Price Target
Maxim Group analyst Jason McCarthy upgrades CNS Pharma (NASDAQ:CNSP) from Hold to Buy and announces $20 price target.
2025-09-12 22:08
